Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.48% | 22.09% | 52.75% | -1,136.54% | -99.64% |
| Total Depreciation and Amortization | 17.10% | 23.64% | 30.63% | 23.03% | 7.20% |
| Total Amortization of Deferred Charges | 33.24% | 51.79% | 105.58% | 118.28% | -13.72% |
| Total Other Non-Cash Items | -0.30% | 10.71% | 8.76% | 5.06% | -21.93% |
| Change in Net Operating Assets | 9.39% | -215.96% | 70.06% | 81.70% | -45.25% |
| Cash from Operations | 3.46% | -36.31% | 85.89% | 66.04% | -689.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -74.69% | -75.00% | -33.33% |
| Total Debt Repaid | 100.00% | 50.00% | -100.00% | 82.95% | 92.19% |
| Issuance of Common Stock | 18.81% | 104.10% | 167.27% | 75.35% | 73.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00% | -50.00% | 67.11% | 86.84% | 89.38% |
| Cash from Financing | -32.21% | -4.51% | -16.28% | -5.46% | 688.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 305.86% | 153.06% | 208.70% | -152.21% | -46.28% |